Ligand · 546
546 · 2-methoxy-6,7-dimethyl-9-(4-methylpyridin-3-yl)imidazo[1,5-a]pyrido[3,2-e]pyrazine
546, 2-methoxy-6,7-dimethyl-9-(4-methylpyridin-3-yl)imidazo[1,5-a]pyrido[3,2-e]pyrazine (C18 H17 N5 O, 319.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5…
- Component
- 546
- Formula
- C18 H17 N5 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
546 in 2 structures; the first of them:
- 3SNI · Highly Potent, Selective, and Orally Active Phosphodiestarase 10A Inhibitors · 546 A782 · binds TYR514, HIS515, LEU625, ASP664, LEU665, SER667, VAL668, ILE682 and 5 more
- 3SNI · Highly potent, selective, and orally active phosphodiestarase 10A inhibitors · 546 A782 · binds TYR514, HIS515, LEU625, ASP664, LEU665, SER667, VAL668, ILE682 and 5 more
Residues it binds most
LEU 4, PHE 4, TYR 4, ASP 4, GLN 4, HIS 4, ILE 4, MET 4, SER 4, VAL 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.